Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines

被引:15
作者
Daoud, Georges [1 ]
Monzer, Alissar [1 ]
Bahmad, Hisham [1 ]
Chamaa, Farah [1 ]
Hamdar, Layal [1 ]
Mouhieddine, Tarek H. [1 ]
Shayya, Sami [1 ]
Eid, Assaad [1 ]
Kobeissy, Firas [2 ]
Liu, Yen-Nien [3 ]
Abou-Kheir, Wassim [1 ]
机构
[1] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon
[3] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan
关键词
prostate cancer; castration-resistant prostate cancer; cancer stem cells; Pten; TP53; OXIDATIVE STRESS; EXPRESSION; TRANSITION; MECHANISMS; DOCETAXEL; GROWTH; BETA;
D O I
10.18632/oncotarget.8436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell lines representing the progression of prostate cancer (PC) from an androgen-dependent to an androgen-independent state are scarce. In this study, we used previously characterized prostate luminal epithelial cell line (Plum), under androgen influence, to establish cellular models of PC progression. Cells derived from orthotopic tumors have been isolated to develop an androgen-dependent (PLum-AD) versus an androgen-independent (PLum-AI) model. Upon immunofluorescent, qRT-PCR and Western blot analyses, PLum-AD cells mostly expressed prostate epithelial markers while PLum-AI cells expressed mesenchymal cell markers. Interestingly, both cell lines maintained a population of stem/progenitor cells. Furthermore, our data suggest that both cell lines are tumorigenic; PLum-AD resulted in an adenocarcinoma whereas PLum-AI resulted in a sarcomatoid carcinoma when transplanted subcutaneously in NOD-SCID mice. Finally, gene expression profiles showed enrichment in functions involved in cell migration, apoptosis, as well as neoplasm invasiveness and metastasis in PLum-AI cells. In conclusion, these data suggest that the newly isolated cell lines represent a new in vitro model of androgen-dependent and -independent PC.
引用
收藏
页码:28961 / 28975
页数:15
相关论文
共 50 条
[21]   Management of castration-resistant prostate cancer: a global approach [J].
Saad, F. .
CURRENT ONCOLOGY, 2012, 19 :S32-S36
[22]   Novel Strategies for Treating Castration-Resistant Prostate Cancer [J].
Leung, David Ka-Wai ;
Chiu, Peter Ka-Fung ;
Ng, Chi-Fai ;
Teoh, Jeremy Yuen-Chun .
BIOMEDICINES, 2021, 9 (04)
[23]   Novel agents for the management of castration-resistant prostate cancer [J].
Haddad, Housam ;
Garcia, Jorge A. .
CURRENT OPINION IN UROLOGY, 2012, 22 (03) :175-182
[24]   Novel options for the treatment of castration-resistant prostate cancer [J].
Carsten-H. Ohlmann ;
Axel S. Merseburger ;
Henrik Suttmann ;
David Schilling ;
Lutz Trojan ;
Carsten Kempkensteffen ;
Stefan Corvin ;
Michael J. Mathers ;
Patrick J. Bastian .
World Journal of Urology, 2012, 30 :495-503
[25]   Cabazitaxel for the treatment of castration-resistant prostate cancer [J].
Agarwal, Neeraj ;
Sonpavde, Guru ;
Sartor, Oliver .
FUTURE ONCOLOGY, 2011, 7 (01) :15-24
[26]   Satraplatin for the therapy of castration-resistant prostate cancer [J].
Sonpavde, Guru ;
Sternberg, Cora N. .
FUTURE ONCOLOGY, 2009, 5 (07) :931-940
[27]   Effect of dutasteride on castration-resistant prostate cancer [J].
Azuma, Takeshi ;
Matayoshi, Yukihide ;
Sato, Yujiro ;
Nagase, Yasuhi .
MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) :133-136
[28]   Castration-Resistant Prostate Cancer An Algorithmic Approach [J].
Stratton, Kelly ;
Cookson, Michael .
UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (04) :647-655
[29]   Strategy in advanced castration-resistant prostate cancer [J].
Gross-Goupil, Marine ;
Roca, Sophie ;
Pasticier, Gilles ;
Ravaud, Alain .
BULLETIN DU CANCER, 2012, 99 :S37-S45
[30]   The Molecular Evolution of Castration-resistant Prostate Cancer [J].
Ceder, Yvonne ;
Bjartell, Anders ;
Culig, Zoran ;
Rubin, Mark A. ;
Tomlins, Scott ;
Visakorpi, Tapio .
EUROPEAN UROLOGY FOCUS, 2016, 2 (05) :506-513